UNIQURE NV's ticker is QURE and the CUSIP is N90064101. A total of 160 filers reported holding UNIQURE NV in Q3 2023. The put-call ratio across all filers is 0.45 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,705,804 | -55.0% | 701,312 | -23.1% | 0.00% | -50.0% |
| Q2 2023 | $10,449,663 | +6.4% | 911,838 | +87.0% | 0.00% | 0.0% |
| Q1 2023 | $9,819,559 | +6.7% | 487,565 | +20.1% | 0.00% | 0.0% |
| Q4 2022 | $9,200,552 | +19.4% | 405,847 | -1.2% | 0.00% | 0.0% |
| Q3 2022 | $7,708,000 | -16.3% | 410,883 | -16.8% | 0.00% | 0.0% |
| Q2 2022 | $9,209,000 | +57.8% | 494,071 | +53.0% | 0.00% | +100.0% |
| Q1 2022 | $5,835,000 | +12.6% | 322,934 | +29.3% | 0.00% | 0.0% |
| Q4 2021 | $5,181,000 | -6.9% | 249,808 | +43.7% | 0.00% | 0.0% |
| Q3 2021 | $5,566,000 | -87.9% | 173,896 | -88.4% | 0.00% | -90.0% |
| Q2 2021 | $46,175,000 | -6.5% | 1,499,199 | +2.3% | 0.01% | -23.1% |
| Q1 2021 | $49,375,000 | +150.1% | 1,465,596 | +168.2% | 0.01% | +160.0% |
| Q4 2020 | $19,746,000 | -4.5% | 546,536 | -2.7% | 0.01% | -16.7% |
| Q3 2020 | $20,678,000 | +8.3% | 561,437 | +32.5% | 0.01% | -14.3% |
| Q2 2020 | $19,094,000 | +52.2% | 423,745 | +60.3% | 0.01% | +16.7% |
| Q1 2020 | $12,543,000 | -70.0% | 264,328 | -54.8% | 0.01% | -66.7% |
| Q4 2019 | $41,860,000 | +15.2% | 584,155 | -36.7% | 0.02% | +5.9% |
| Q3 2019 | $36,347,000 | -49.0% | 923,442 | +1.2% | 0.02% | -48.5% |
| Q2 2019 | $71,290,000 | +446.9% | 912,221 | +317.4% | 0.03% | +450.0% |
| Q1 2019 | $13,036,000 | -7.8% | 218,534 | -55.4% | 0.01% | -25.0% |
| Q4 2018 | $14,137,000 | +47.5% | 490,496 | +86.2% | 0.01% | +60.0% |
| Q3 2018 | $9,587,000 | +49.3% | 263,433 | +55.0% | 0.01% | +66.7% |
| Q2 2018 | $6,423,000 | -14.5% | 169,918 | -46.8% | 0.00% | -25.0% |
| Q1 2018 | $7,513,000 | +738.5% | 319,685 | +599.3% | 0.00% | – |
| Q4 2017 | $896,000 | +400.6% | 45,717 | +42.9% | 0.00% | – |
| Q4 2016 | $179,000 | +26.1% | 31,984 | +72.9% | 0.00% | – |
| Q3 2016 | $142,000 | -72.2% | 18,500 | -73.3% | 0.00% | -100.0% |
| Q2 2016 | $511,000 | +322.3% | 69,348 | +582.4% | 0.00% | – |
| Q1 2016 | $121,000 | +181.4% | 10,162 | +286.5% | 0.00% | – |
| Q4 2015 | $43,000 | -94.9% | 2,629 | -93.6% | 0.00% | -100.0% |
| Q3 2015 | $843,000 | -7.1% | 41,237 | +22.8% | 0.00% | 0.0% |
| Q2 2015 | $907,000 | +153.4% | 33,580 | +127.9% | 0.00% | – |
| Q1 2015 | $358,000 | -31.9% | 14,735 | -56.4% | 0.00% | -100.0% |
| Q1 2014 | $526,000 | – | 33,814 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 155,500 | $11,803,000 | 2.66% |
| Aquilo Capital Management, LLC | 901,490 | $16,290,000 | 2.39% |
| Nantahala Capital Management | 2,811,459 | $50,803,000 | 2.25% |
| Privium Fund Management B.V. | 493,229 | $8,913,000 | 1.97% |
| 683 Capital Management, LLC | 1,355,000 | $24,485,000 | 1.31% |
| Henry James International Management Inc. | 125,622 | $2,270,000 | 0.90% |
| Integral Health Asset Management, LLC | 170,000 | $3,072,000 | 0.80% |
| Nantahala Capital Management | 890,000 | $16,082,000 | 0.71% |
| Sonic Fund II, L.P. | 50,000 | $904,000 | 0.51% |
| Voss Capital, LLC | 70,000 | $1,265,000 | 0.40% |